SCHEMBL3453529

SCHEMBL3453529

COC(=O)c1ccc(-c2cc(Cl)c(C(C3CCc4[nH]cnc4C3)C3CCNC3=O)c(Cl)c2)cc1

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 1/20 0.33
IP6K1 Q92551 1/20 0.32
RHEB Q15382 1/20 0.32
MAPT P10636 1/20 0.32
WNT3A P56704 1/20 0.31
TNKS2 Q9H2K2 1/20 0.31
HSD11B1 P28845 2/20 0.31
SLC6A4 P31645 1/20 0.31
SLC6A3 Q01959 1/20 0.31
PSD A5PKW4 1/20 0.31
KDM5B Q9UGL1 1/20 0.30
HDAC8 Q9BY41 1/20 0.30
GAA P10253 1/20 0.30
CDK9 P50750 1/20 0.30
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL208949 0.79 RHEB (0.36) MEN1KMT2AKDM4EALDH1A1IP6K1
SCHEMBL474994 0.78 KDM4E (0.35) KDM4EALDH1A1IP6K1RHEBMAPT
SCHEMBL207570 0.77 MAP2K4 (0.35) KDM4EALDH1A1IP6K1RHEBMAPT
SCHEMBL2994149 0.71 ALDH1A1 (0.35) KMT2AALDH1A1RHEBMAPT
SCHEMBL2065311 0.71 ALDH1A1 (0.40) ALDH1A1MAPTSLC6A4SLC6A3HPGD
SCHEMBL2999303 0.71 SLC6A3 (0.40) MEN1KMT2AALDH1A1SLC6A4SLC6A3
SCHEMBL4060990 0.68 SRD5A2 (0.32) TNKS2
SCHEMBL208541 0.68 SRD5A2 (0.32) TNKS2
SCHEMBL209419 0.68 POLB (0.37) MEN1KMT2AKDM4EALDH1A1MAPT
SCHEMBL1092147 0.68 PSD (0.35) ALDH1A1RHEBPSDKDM5BHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029576-B1 CYCLOHEXYLIMIDAZOLE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2013-06-19 EP claimed
US-7820659-B2 Cyclohexylimidiazole lactam derivatives as inhibitors of 11-β-hydroxysteroid dehydrogenase 1 ELI LILLY AND COMPANY (US) 2010-10-26 US claimed
US-20090088428-A1 CYCLOHEXYLIMIDIAZOLE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY 2009-04-02 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090088428-A1 CYCLOHEXYLIMIDIAZOLE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 HSD11B1, HSD17B1, HSD11B2 MEN1 1555/4885KMT2A 920/4885KDM4E 1255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.